产品信息
| 产品号 | 商品名 | 活性成分 | 剂型/给药途径 | 规格/剂量 | 参比药物(RLD) | 生物等效参考标准(RS) | 治疗等效代码 | 该申请号批准日期 | 该产品号批准日期 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|
| 001 | EMBEDA | MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No | None | 2009/08/13 | 2009/08/13 | Discontinued |
| 002 | EMBEDA | MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No | None | 2009/08/13 | Discontinued | |
| 003 | EMBEDA | MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No | None | 2009/08/13 | Discontinued | |
| 004 | EMBEDA | MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No | None | 2009/08/13 | Discontinued | |
| 005 | EMBEDA | MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No | None | 2009/08/13 | Discontinued | |
| 006 | EMBEDA | MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No | None | 2009/08/13 | Discontinued |
